Have your say
We encourage stakeholders to actively participate in consultations about the reforms and provide any ideas for Prescribed List improvement. This helps us make sure it is strong and fit for purpose.
If you would like us to notify you of upcoming consultations, contact us to add you to the Private Health Insurance Circular distribution list.
Learn more about the consultations for the reforms.
Reforms
- Modernising the application process
Learn about the new advisory committee, expert clinical advisory groups and listing pathways. - Modernising Part B (human tissue products) of the Prescribed List
Learn about the proposed reforms to Part B of the Prescribed List. - Reducing the public and private sector price gap
Learn about previous and future reductions to Prescribed List benefits, and when they will be implemented. - Benefit reductions for Cardiac Implantable Electronic Devices (CIEDs)
Learn about how we are reducing Prescribed List benefits for CIEDs. - General use items (GUI)
Learn about General Use Items on the Prescribed List. - Changes in legislation
Learn about legislation changes to the Private Health Insurance Act 2007 and related legislation. - Improving compliance and assurance
Learn about the proposed compliance and assurance measures to safeguard the Prescribed List. - Moving applications to the Health Products Portal
Learn about the new application portal and important dates.
Contact
Prescribed List contact
Contact us if you have questions about the Prescribed List, the Medical Devices and Human Tissue Advisory Committee (MDHTAC)
or Expert Clinical Advisory Groups (ECAGs).
or Expert Clinical Advisory Groups (ECAGs).
Date last updated: